Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Grupos

Abstract

Noninvasive detection of primary graft dysfunction (PGD) remains a major challenge. SERCA2a plays an important role in cardiac homeostasis and its dysregulation has been associated with ventricular dysfunction and rejection. This study aimed to determine the potential utility of plasma levels of SERCA2a as a biomarker of PGD.

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0041-1337, 1534-6080

TRANSPLANTATION  LIPPINCOTT WILLIAMS & WILKINS

Tipo:
Article
Páginas:
887-893
PubMed:
33901112
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
1,407 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 11

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • INTERNATIONAL SOCIETY; FAILURE

Campos de Estudio

Cita

Compartir